To help Positron Emission Tomography (PET) based molecular imaging realize its full potential in translational experimental medicine by advising organizations how PET could be fully developed and exploited within their individual circumstances.
Strengths: PET is the most sensitive and specific methodology for imaging regional tissue molecular interactions and pathways in humans. It provides the means to bridge or translate between laboratory discoveries to experimental medicine and health care procedures
Weakness: PET is significantly underdeveloped and has yet to fully impact as a clinical research procedure across internal medicine.
The PET RESEARCH ADVISORY Co based upon on experience, will facilitate and provide independent advice on:
Options, strategies and the practicalities of realizing the full scientific potential of an organization’s current or future investments in PET
This commercial advisory approach represents a new model to address the challenges in realizing the full potential of PET in experimental medicine.